Literature DB >> 18237802

The cost of radiation therapy.

Nicolas Paul Ploquin1, Peter Brian Dunscombe.   

Abstract

BACKGROUND AND
PURPOSE: The rising cost of health care is of universal concern. If the cost effectiveness of conventional and novel radiotherapeutic strategies is to be established we need to have confidence in our estimates of both cost and effectiveness. The purpose of this study is to explore the degree of consistency of recently published cost estimates for radiation therapy. METHODS AND MATERIALS: Eleven publications form the basis of this analysis. From each study we have estimated the cost of a 21 fraction course (when possible) of radiation therapy. The costs have been decomposed into the three inputs: process, clinical infrastructure and supporting infrastructure. We have also investigated the time course of radiation therapy costs over the last two decades.
RESULTS: From the latest four studies we conclude that the cost of a 21 fraction course of radiation therapy is 3239 euro+/-566 euro. The percentages of this total spent on process, clinical infrastructure and supporting infrastructure over the last 15 years are 54, 29 and 17, respectively. The real increase in the cost of radiotherapy over the last 15 years is estimated to be approximately 5.5%.
CONCLUSION: Cost estimates for radiation therapy appear to be converging. However, we will need far more sophisticated analyses in the future if we are to establish the cost effectiveness of the newer treatment strategies currently under active clinical investigation.

Entities:  

Mesh:

Year:  2008        PMID: 18237802     DOI: 10.1016/j.radonc.2008.01.005

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  Cost of care for colorectal cancer in Ireland: a health care payer perspective.

Authors:  L Tilson; L Sharp; C Usher; C Walsh; Whyte S; A O'Ceilleachair; C Stuart; B Mehigan; M John Kennedy; P Tappenden; J Chilcott; A Staines; H Comber; M Barry
Journal:  Eur J Health Econ       Date:  2011-06-03

2.  Evaluation of time, attendance of medical staff and resources for radiotherapy in pediatric and adolescent patients. The DEGRO-QUIRO trial.

Authors:  Angelika Zabel-du Bois; Stefanie Milker-Zabel; Frank Bruns; Hans Christiansen; Iris Ernst; Normann Willich; Wolfgang Popp; Jürgen Debus; Horst Sack
Journal:  Strahlenther Onkol       Date:  2014-04-01       Impact factor: 3.621

3.  [Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery : QUIRO-DEGRO Trial].

Authors:  A Zabel-du Bois; S Milker-Zabel; M Henzel; W Popp; J Debus; H Sack; R Engenhart-Cabillic
Journal:  Strahlenther Onkol       Date:  2012-08-01       Impact factor: 3.621

4.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial.

Authors:  E Blank; N Willich; R Fietkau; W Popp; J Schaller-Steiner; H Sack; F Wenz
Journal:  Strahlenther Onkol       Date:  2012-01-14       Impact factor: 3.621

5.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial.

Authors:  Wilfried Budach; Edwin Bölke; Rainer Fietkau; Andre Buchali; Thomas G Wendt; Wolfgang Popp; Christiane Matuschek; Horst Sack
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

6.  Estimating the costs of intensity-modulated and 3-dimensional conformal radiotherapy in Ontario.

Authors:  J H E Yong; T McGowan; R Redmond-Misner; J Beca; P Warde; E Gutierrez; J S Hoch
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

7.  Direct costs of radiotherapy for rectal cancer: a microcosting study.

Authors:  Paul Hanly; Alan Ó Céilleachair; Máiréad Skally; Ciaran O'Neill; Linda Sharp
Journal:  BMC Health Serv Res       Date:  2015-05-02       Impact factor: 2.655

8.  The changes of radiotherapy in Lithuania: infrastructure, utilization rate, and cost.

Authors:  Ramunė Mineikytė; Ernestas Janulionis; Vydmantas Atkočius; Laimonas Jaruševičius; Aista Plieskienė; Jonas Gečas
Journal:  Acta Med Litu       Date:  2016

9.  Estimation of radiotherapy modalities for patients with stage I-II nasal natural killer T-Cell lymphoma.

Authors:  Xianfeng Liu; Furong Wu; Qishuai Guo; Ying Wang; Yanan He; Huanli Luo; Qicheng Li; Mingsong Zhong; Chao Li; Han Yang; Juan Zhou; Fu Jin
Journal:  Cancer Manag Res       Date:  2019-07-30       Impact factor: 3.989

10.  Evaluating the attendance of medical staff and room occupancy during palliative radiotherapy.

Authors:  Irenäus A Adamietz; Oliver Micke; Wolfgang Popp; Horst Sack
Journal:  Strahlenther Onkol       Date:  2014-05-13       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.